Curis Inc
$1.09
Market Cap
$2.72M
Shares Outstanding
2.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Aug 1, 2000
Round Lot
100
Locale
US
Day Open
$1.12
Day High
$1.18
Day Low
$1.07
Volume
139.4K
VWAP
$1.12
Prev Close
$1.12
Transactions
--
Acc. Volume
--
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Curis Inc (CRIS) closed the 2026-09-17 session at $1.09, down 2.68% versus the previous close (-0.03). The stock opened at $1.12 and traded between $1.07 and $1.18 during that session. Session trading volume was 139K shares. The volume-weighted average price (VWAP) is $1.12.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Curis Inc has a market capitalization of $2.7 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. CRIS is listed on the XNAS exchange. The company employs approximately 24 people. Curis Inc is headquartered in LEXINGTON, MA. The recorded listing date is 2000-08-01.
On this page you can find market CRIS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.